Issue 5, 2016
From the journal:

Nanoscale Horizons

Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain†

Jinmyoung Joo, ORCID logo ‡a   Ester J. Kwon,b   Jinyoung Kang,c   Matthew Skalak,b   Emily J. Anglin,a   Aman P. Mann,d   Erkki Ruoslahti,de   Sangeeta N. Bhatiabfghij  and  Michael J. Sailor*ac  

* Corresponding authors

a Department of Chemistry, University of California, San Diego, La Jolla, CA 92093, USA
E-mail: msailor@ucsd.edu

b Harvard-MIT Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

c Department of Nanoengineering, University of California, San Diego, La Jolla, CA 92093, USA

d Cancer Research Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA

e Center for Nanomedicine and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA

f Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

g David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

h Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA

i Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA

j Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA

Abstract

We report the synthesis, characterization, and assessment of a nanoparticle-based RNAi delivery platform that protects siRNA payloads against nuclease-induced degradation and efficiently delivers them to target cells. The nanocarrier is based on biodegradable mesoporous silicon nanoparticles (pSiNPs), where the voids of the nanoparticles are loaded with siRNA and the nanoparticles are encapsulated with graphene oxide nanosheets (GO–pSiNPs). The graphene oxide encapsulant delays release of the oligonucleotide payloads in vitro by a factor of 3. When conjugated to a targeting peptide derived from the rabies virus glycoprotein (RVG), the nanoparticles show 2-fold greater cellular uptake and gene silencing. Intravenous administration of the nanoparticles into brain-injured mice results in substantial accumulation specifically at the site of injury.

Graphical abstract: Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C6NH00082G
Article type
Communication
Submitted
06 5月 2016
Accepted
14 6月 2016
First published
14 6月 2016

Nanoscale Horiz., 2016,1, 407-414

Permissions

Request permissions

Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain

J. Joo, E. J. Kwon, J. Kang, M. Skalak, E. J. Anglin, A. P. Mann, E. Ruoslahti, S. N. Bhatia and M. J. Sailor, Nanoscale Horiz., 2016, 1, 407 DOI: 10.1039/C6NH00082G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements